+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Single Photon Emission Computed Tomography (SPECT) - Global Strategic Business Report

  • PDF Icon

    Report

  • 469 Pages
  • December 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5140130
The global market for Single Photon Emission Computed Tomography (SPECT) is estimated at US$2.1 Billion in 2023 and is projected to reach US$3.3 Billion by 2030, growing at a CAGR of 7.1% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The growth in the SPECT market is driven by several factors. Increasing prevalence of chronic diseases such as cardiovascular diseases, cancer, and neurological disorders is a major driver, as these conditions often require detailed functional imaging for diagnosis and management. Technological advancements, including the development of hybrid SPECT/CT systems and improvements in detector materials and image processing algorithms, have significantly enhanced the clinical utility and adoption of SPECT. Additionally, the growing emphasis on personalized medicine and the need for precise diagnostic tools to tailor treatments to individual patients are fueling demand for advanced imaging modalities like SPECT. The rising geriatric population, which is more susceptible to chronic diseases, further expands the potential market for SPECT. Lastly, the increasing availability of radiopharmaceuticals and the expansion of nuclear medicine facilities worldwide are also contributing to market growth. These factors collectively underscore the dynamic and evolving nature of the SPECT market.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Cardiology Application segment, which is expected to reach US$1.3 Billion by 2030 with a CAGR of a 8.1%. The Oncology Application segment is also set to grow at 7.1% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $738.1 Million in 2023, and China, forecasted to grow at an impressive 9.7% CAGR to reach $399.5 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Single Photon Emission Computed Tomography (SPECT) Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Single Photon Emission Computed Tomography (SPECT) Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Single Photon Emission Computed Tomography (SPECT) Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as GE Healthcare, Cardinal Health, Inc., Bruker Corporation, and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 45 Featured):

  • GE Healthcare
  • Cardinal Health, Inc.
  • Bruker Corporation
  • Agfa-Gevaert NV
  • Analogic Corporation
  • Biosensors International Group Ltd.
  • Koninklijke Philips N.V.
  • Bracco SpA
  • Digirad Corporation
  • Bracco Imaging SpA
  • CMR Naviscan Corporation
  • BC Technical, Inc.
  • DDD-Diagnostic A/S
  • Cubresa Inc.
  • Beijing Hamamatsu Photon Techniques, Inc.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Single Photon Emission Computed Tomography (SPECT) - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • A Prelude to Single-Photon Emission Computed Tomography (SPECT)
  • Prominent Indications for SPECT Scanning
  • Global SPECT Market to Witness Steady Growth over the Coming Years
  • Hybrid SPECT Systems Witness Increased Demand.
  • Cardiology Dominates the Application for SPECT
  • Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
  • United States Dominates the Global SPECT Market, Asia-Pacific to Register Faster Growth
  • Competition
  • Recent Market Activity
  • WORLD BRANDS
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • SPECT Dominates the Nuclear Medicine Market
  • Global Radiopharmaceuticals Market Revenues in U$ Million for Years 2019, 2021, 2023 & 2025
  • SPECT Systems with Anger Camera Remain the Dominant Type
  • Rapidly Growing Geriatric Population and the Rise in Associated Diseases Catalyze Growth
  • Global Population of 65+ Individuals (In 000s) by Region for the Years 2015, 2020, 2025, 2030 & 2050
  • Rising Incidence of Chronic Diseases Propels the Demand for Medical Imaging
  • Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030
  • Oncology Diagnostic Imaging to Witness Rapid Growth
  • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
  • Growing Emphasis on Early Diagnosis is a Driving Factor for Diagnostic Imaging
  • Rise in Healthcare Expenditure to Drive Growth
  • Elderly Healthcare Expenditure as a % of GDP
  • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
  • SPECT Systems with Anger Camera Remain the Dominant Type
  • Growing Demand for Dual-Modality and Organ-Specific Systems Augurs Well
  • Growing Adoption of Hybrid Diagnostic Imaging Modalities
  • SPECT-CT
  • Commercialization of SPECT/CT Systems with Enhanced Features Surges
  • SPECT Combined with CT and PET, the new Rage
  • Integration of X-ray CT Enhances SPECT Capabilities
  • Proper Selection of Isotopes Highly Important for SPECT
  • Sustained Opportunities for Ga-67 SPECT Systems
  • PET Eclipses SPECT in Cardiovascular Imaging
  • Personalized Medicine Drives SPECT Market
  • Drug Ineffectiveness for Select Therapeutic Categories as a Percentage of Patient Population
  • Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019 and 2024
  • Rise in Incidence of Neurological Disorders to Drive Growth
  • Technological Advancements in the Recent Past
  • Yale University Research Team Attempts to use Deep Learning for Estimating Attenuation Maps using SPECT Emission Data
  • Siemens Healthineers Debuts New Version of c.cam Cardiac SPECT System
  • NorthStar Medical Radioisotopes Advances Focus on Therapeutic and Specialized SPECT Radiopharmaceuticals
  • Technological Advancements in Cardiac SPECT
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Standalone by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 2: World Historic Review for Standalone by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 3: World 16-Year Perspective for Standalone by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Hybrid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 5: World Historic Review for Hybrid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 6: World 16-Year Perspective for Hybrid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 8: World Historic Review for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 9: World 16-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 11: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 12: World 16-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 14: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 15: World 16-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 17: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 18: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 20: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 21: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 23: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 24: World 16-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 25: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 26: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 27: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 28: World Single Photon Emission Computed Tomography (SPECT) Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • Table 29: World Recent Past, Current & Future Analysis for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 30: World Historic Review for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 31: World 16-Year Perspective for Single Photon Emission Computed Tomography (SPECT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
CANADA
JAPAN
  • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
CHINA
  • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
EUROPE
  • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
FRANCE
  • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
GERMANY
  • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
ITALY
UNITED KINGDOM
  • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
AUSTRALIA
  • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
  • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Single Photon Emission Computed Tomography (SPECT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
IV. COMPETITION

Companies Mentioned

  • GE Healthcare
  • Cardinal Health, Inc.
  • Bruker Corporation
  • Agfa-Gevaert NV
  • Analogic Corporation
  • Biosensors International Group Ltd.
  • Koninklijke Philips N.V.
  • Bracco SpA
  • Digirad Corporation
  • Bracco Imaging SpA
  • CMR Naviscan Corporation
  • BC Technical, Inc.
  • DDD-Diagnostic A/S
  • Cubresa Inc.
  • Beijing Hamamatsu Photon Techniques, Inc.

Table Information